Marcus Low

Analysis: Not all good news in new WHO MDR-TB recommendations

In a move that could help save the hearing of thousands of people with TB, the World Health Organisation (WHO) is advising wider use of newer and repurposed drugs, bedaquiline and linezolid in place of injections that cause deafness. Rather perplexingly, the WHO is however also maintaining its recommendation for a shorter and cheaper, but much less impressive treatment regimen and advised that the new South African regimen should only be used under conditions of operational research.

Read More →

Moment of truth for global TB response

Marcus Low's reflections on the Global Ministerial Conference on TB held on 16-17 November 2017 in Moscow, Russia.

Read More →

South Africa: How a patent is blocking access to a life-saving TB medicine

Médecins Sans Frontières would like to treat 300 drug resistant TB patients in Khayelitsha with linezolid, but can only afford to buy the drug for little more than 20 patients.

Read More →

Page 1 of 1 · Total posts: 3

1